Medical Devices Business Equity Stake For Sale in Dubai, UAE
Pre-revenue regenerative medicine company developing organ-specific ECM hydrogel platforms for advanced tissue repair and healing.
Premium Plan
| Established | 5-10 year(s) |
| Employees | 10 - 50 |
| Legal Entity | General Partnership |
| Reported Sales | Nil |
| Run Rate Sales | Nil |
| EBITDA Margin | Nil |
| Industries | Medical Devices |
| Locations | Dubai |
| Local Time | 10:54 AM Asia / Dubai |
| Listed By | Management Member |
| Status | Active |
Partial Stake Sale
USD
50 million
for
30.0%
stake
(Native Currency: USD 50,000,000)
Reason: We’re exploring milestone-based investment to accelerate clinical and manufacturing progress.
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Business Overview
- Pre-revenue regenerative medicine company developing organ-specific decellularized ECM (extracellular matrix) hydrogel platforms for tissue regeneration.
- Core technology focuses on organ-derived ECM hydrogels designed to support chronic wound healing, full-thickness wound repair, surgical recovery, and advanced tissue regeneration applications.
- Product development is being carried out in collaboration with a university research partner in Japan, supporting scientific validation and translational research.
- Planned commercialization strategy follows a distributor-centric expansion model, targeting rollout across up to 120 countries.
- Initial international expansion is planned through cluster offices in the MENA region and Western Europe.
- The business is currently in the technology development and validation phase, with no commercial revenues generated to date.
- Holds a valid trade license, ensuring a compliant and structured setup for future commercialization.
- Core technology focuses on organ-derived ECM hydrogels designed to support chronic wound healing, full-thickness wound repair, surgical recovery, and advanced tissue regeneration applications.
- Product development is being carried out in collaboration with a university research partner in Japan, supporting scientific validation and translational research.
- Planned commercialization strategy follows a distributor-centric expansion model, targeting rollout across up to 120 countries.
- Initial international expansion is planned through cluster offices in the MENA region and Western Europe.
- The business is currently in the technology development and validation phase, with no commercial revenues generated to date.
- Holds a valid trade license, ensuring a compliant and structured setup for future commercialization.
Products & Services Overview
Organ-specific decellularized ECM hydrogel platforms intended for use in advanced wound care, surgical recovery, and regenerative medicine applications.
Assets Overview
The business currently does not own any tangible assets.
Facilities Overview
Operates from a rented office in Dubai.
Capitalization Overview
The business is owned by a total of four partners, and all Research and Development processes have not been funded by them for the past seven years.
Tags:
Medical Equipment Business Investment Opportunity in Dubai, UAE
·Medical Equipment Business Equity Stake For Sale in Dubai, UAE
·Medical Devices Business Investment Opportunity in Dubai, UAE
·Medical Devices Business Equity Stake For Sale in Dubai, UAE
·Invest in Medical Equipment Business in Dubai, UAE
·Medical Equipment Business Investment Opportunity
·Invest in Medical Devices Business in Dubai, UAE
·Medical Devices Business Investment Opportunity
·Investment Opportunity in Dubai, UAE
·Invest in Medical Equipment Business
·Invest in Medical Devices Business
·Invest in Dubai, UAE
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
6 Investors viewed this Business this week.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 63,500+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses